Overview

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Status:
Completed
Trial end date:
2017-03-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Imatinib is safe and effective in association with intensive treatment of Ph+ALL in children.
Phase:
Phase 2
Details
Lead Sponsor:
Rennes University Hospital
Collaborators:
Ministry of Health, France
Novartis
Treatments:
Imatinib Mesylate